Telix Pharmaceuticals Ltd (TLX) stock
TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
$9.23−0.13 (-1.39%)
Close on Nov 13, 2026Market cap $3.13BP/E –Yield –
Telix Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Telix Pharmaceuticals's enterprise value was $3.55B on Nov 11, 2026, against $3.35B a year earlier. Over the last 2 years it ranged from $2.43B to $5.94B, with a median of $3.97B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.55B | +42.1% |
| 2025 | Dec 31, 2025 | $2.50B | -49.1% |
| 2024 | Dec 31, 2024 | $4.91B | – |
See a number that looks wrong?